Efficacy of Twice Daily Fluticasone Propionate and Formoterol Fumarate Combination Administered Using an HFA pMDI in Patients with Mild to Moderate Asthma

被引：0
|
作者：
D'Urzo, A. D. [1 ]
Nathan, R. A. [2 ]
Kaiser, K. [3 ]
Renz, C. L. [4 ]
Jain, R. I. [4 ]
Perdok, R. J. [4 ]
Doan, T. T. [4 ]
机构：
[1] Primary Care Lung Clin, Toronto, ON, Canada
[2] Asthma & Allergy Associates, PC, Colorado Springs, CO USA
[3] SkyePharma, Muttenz, Switzerland
[4] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2009年 / 123卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2008.12.275
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
292
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [1] Efficacy of Twice Daily Fluticasone Propionate and Formoterol Fumarate Combination Administered Using an HFA pMDI in Patients with Moderate to Severe Asthma
    Corren, J.
    Mansfield, L. E.
    Kaiser, K.
    Renz, C. L.
    Jain, R. I.
    Perdok, R. J.
    Doan, T. T.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S157 - S157
  • [2] Twice-Daily Fluticasone Propionate (FP)/Formoterol Fumarate (FM) HFA pMDI Combination Therapy Is Safe, Efficacious and Reduces Asthma Exacerbations in Patients with Mild to Moderate Asthma.
    Nathan, R.
    D'Urzo, A.
    Kaiser, K.
    Renz, C.
    Jain, R.
    Perdok, R.
    Doan, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [3] Twice-Daily Fluticasone Propionate (FP)/Formoterol Fumarate (FM) HFA pMDI Combination Therapy Is Safe, Efficacious and Reduces Asthma Exacerbations in Patients with Moderate to Severe Asthma.
    Corren, J.
    Mansfield, L.
    Kaiser, K.
    Renz, C.
    Jain, R.
    Perdok, R.
    Doan, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [4] Clinical efficacy and safety of fluticasone propionate 250 μg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma
    Tonnel, AB
    Bons, J
    Legendre, M
    Prud'Homme, A
    Bugnas, B
    Evano-Celli, I
    Stuart, AM
    RESPIRATORY MEDICINE, 2000, 94 : S29 - S34
  • [5] Fluticasone propionate aerosol: Efficacy in patients with mild to moderate asthma
    Sheffer, AL
    LaForce, C
    Chervinsky, P
    Pearlman, D
    Schaberg, A
    JOURNAL OF FAMILY PRACTICE, 1996, 42 (04): : 369 - 375
  • [6] FLUTICASONE PROPIONATE/FORMOTEROL FUMARATE COMBINATION THERAPY IS SUPERIOR TO FLUTICASONE PROPIONATE ALONE IN IMPROVING ASTHMA CONTROL
    Price, D.
    Papi, A.
    Tamm, M.
    Kaiser, K.
    Grothe, B.
    Lomax, M.
    McIver, T.
    THORAX, 2011, 66 : A113 - A113
  • [7] Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis
    Papi, Alberto
    Price, David
    Sastre, Joaquin
    Kaiser, Kirsten
    Lomax, Mark
    McIver, Tammy
    Dissanayake, Sanjeeva
    RESPIRATORY MEDICINE, 2015, 109 (02) : 208 - 217
  • [8] Once daily inhaled fluticasone propionate is as effective as twice daily in children with stable mild to moderate asthma
    Hodges, I
    Netherway, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A139 - A139
  • [9] Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma
    ZuWallack, R
    Adelglass, J
    Clifford, DP
    Duke, SP
    Wire, PD
    Faris, M
    Harding, SM
    CHEST, 2000, 118 (02) : 303 - 312
  • [10] Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma
    Price, David
    Hillyer, Elizabeth V.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (03) : 275 - 291
12345